<?xml version="1.0" encoding="UTF-8"?>
<!-- Image entries carry the eight content diagrams. They are the only assets here
     built to be taken away: CC BY 4.0, with an embed snippet on the page. -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://rafihive.com/</loc>
    <lastmod>2026-09-19</lastmod>
    <changefreq>weekly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://rafihive.com/pricing</loc>
    <lastmod>2026-09-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://rafihive.com/sample-output</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://rafihive.com/sources</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
    <image:image>
      <image:loc>https://rafihive.com/assets/diagrams/regulatory-source-hierarchy.png</image:loc>
      <image:title>What binds and what only guides: legislation, guidance, questions and answers, templates, then agency practice — with draft and superseded material kept outside the hierarchy rather than blended into it.</image:title>
      <image:license>https://creativecommons.org/licenses/by/4.0/</image:license>
    </image:image>
  </url>
  <url>
    <loc>https://rafihive.com/ai-governance</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://rafihive.com/evaluation</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://rafihive.com/use-cases</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://rafihive.com/regulatory-affairs-ai-agent</loc>
    <lastmod>2026-09-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://rafihive.com/gap-check</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://rafihive.com/packaging-check</loc>
    <lastmod>2026-08-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.9</priority>
  </url>
  <url>
    <loc>https://rafihive.com/security</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://rafihive.com/about</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://rafihive.com/contact</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://rafihive.com/privacy</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.3</priority>
  </url>
  <url>
    <loc>https://rafihive.com/terms</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.3</priority>
  </url>
  <url>
    <loc>https://rafihive.com/imprint</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>yearly</changefreq>
    <priority>0.3</priority>
  </url>
  <url>
    <loc>https://rafihive.com/guides</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://rafihive.com/guides/eu-variation-classification</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
    <image:image>
      <image:loc>https://rafihive.com/assets/diagrams/eu-variation-classification-decision-tree.png</image:loc>
      <image:title>Classifying an EU post-authorisation change: screen Annex I of the Variations Regulation for an extension first, then work through the Classification Guideline's scope and conditions.</image:title>
      <image:license>https://creativecommons.org/licenses/by/4.0/</image:license>
    </image:image>
  </url>
  <url>
    <loc>https://rafihive.com/guides/eu-ectd-module-1</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
    <image:image>
      <image:loc>https://rafihive.com/assets/diagrams/eu-ectd-module-1-section-map.png</image:loc>
      <image:title>EU eCTD Module 1, section by section: 1.0 to 1.2 and the product information in 1.3 against the conditional sections 1.4 to 1.10.</image:title>
      <image:license>https://creativecommons.org/licenses/by/4.0/</image:license>
    </image:image>
  </url>
  <url>
    <loc>https://rafihive.com/guides/mrp-dcp-variations</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://rafihive.com/guides/centralised-procedure-variations</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://rafihive.com/guides/nitrosamine-risk-assessment</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
    <image:image>
      <image:loc>https://rafihive.com/assets/diagrams/nitrosamine-risk-assessment-three-steps.png</image:loc>
      <image:title>The three-step EU nitrosamine exercise, with the question that decides whether each step holds — and how the applicable limit is set.</image:title>
      <image:license>https://creativecommons.org/licenses/by/4.0/</image:license>
    </image:image>
  </url>
  <url>
    <loc>https://rafihive.com/guides/elemental-impurities-ich-q3d</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
    <image:image>
      <image:loc>https://rafihive.com/assets/diagrams/ich-q3d-elemental-impurities-approaches.png</image:loc>
      <image:title>The drug product, component and summation approaches of ICH Q3D side by side. All three end at the same decision point: 30% of the permitted daily exposure.</image:title>
      <image:license>https://creativecommons.org/licenses/by/4.0/</image:license>
    </image:image>
  </url>
  <url>
    <loc>https://rafihive.com/guides/asmf-or-cep</loc>
    <lastmod>2026-08-14</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
    <image:image>
      <image:loc>https://rafihive.com/assets/diagrams/asmf-cep-full-details-route-comparison.png</image:loc>
      <image:title>The three routes to section 3.2.S — full details, a Certificate of Suitability, or an Active Substance Master File — and what the applicant owes whichever is used.</image:title>
      <image:license>https://creativecommons.org/licenses/by/4.0/</image:license>
    </image:image>
  </url>
  <url>
    <loc>https://rafihive.com/insights</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://rafihive.com/insights/eu-variations-2026</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://rafihive.com/insights/eu-pharmaceutical-legislation-reform-2026</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://rafihive.com/insights/electronic-product-information-epi-2026</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
    <image:image>
      <image:loc>https://rafihive.com/assets/diagrams/epi-product-information-data-flow.png</image:loc>
      <image:title>What ePI changes: the unit of work stops being a QRD document and becomes structured FHIR data managed through EMA's PLM Portal — which changes how far a single error reaches.</image:title>
      <image:license>https://creativecommons.org/licenses/by/4.0/</image:license>
    </image:image>
  </url>
  <url>
    <loc>https://rafihive.com/insights/ectd-v4-eu-transition</loc>
    <lastmod>2026-09-19</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
    <image:image>
      <image:loc>https://rafihive.com/assets/diagrams/ectd-v4-eu-transition-timeline.png</image:loc>
      <image:title>EMA's published eCTD v4.0 plan for new centrally authorised MAAs: optional since December 2025, strongly recommended from Q1 2027, mandatory from Q1 2028. The dates have moved before.</image:title>
      <image:license>https://creativecommons.org/licenses/by/4.0/</image:license>
    </image:image>
  </url>
  <url>
    <loc>https://rafihive.com/insights/what-is-a-regulatory-affairs-ai-agent</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://rafihive.com/insights/hallucinated-citations-regulatory-ai</loc>
    <lastmod>2026-09-17</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.8</priority>
  </url>
</urlset>
